Aspira Pathlab

{
  "main_header": {
    "sid": 1002885,
    "name": "Aspira Pathlab",
    "stock_name": "Aspira Pathlab",
    "full_name": "Aspira Pathlab & Diagnostics Ltd",
    "name_url": "stocks-analysis/aspira-pathlab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "91.00",
    "chg": -4.39,
    "chgp": "-4.6%",
    "dir": -1,
    "prev_price": "95.39",
    "mcapval": "93.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 540788,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE500C01017",
    "curr_date": "Sep 02, 11:42 AM",
    "curr_time": "12:07 PM",
    "last_traded_at": "Sep 02, 11:42 AM IST",
    "bse_nse_vol": 437,
    "exc_status": "Active",
    "traded_date": "Sep 02, 2026",
    "traded_date_str": "2026 09 02",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/aspira-pathlab-1002885-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-amp-diagnostics-ltd-is-rated-sell-4165910",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AspiraPathlabDi_mojoScore_4165910.png",
        "date": "2026-08-23 10:10:27",
        "description": "Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-amp-diagnostics-ltd-is-rated-sell-4147179",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AspiraPathlabDi_mojoScore_4147179.png",
        "date": "2026-08-11 10:10:57",
        "description": "Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "When is the next results date for Aspira Pathlab & Diagnostics Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-aspira-pathlab-diagnostics-ltd-4142469",
        "imagepath": "",
        "date": "2026-08-07 23:20:59",
        "description": "The next results date for Aspira Pathlab & Diagnostics Ltd is scheduled for 12 August 2026...."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-amp-diagnostics-ltd-is-rated-sell-4130189",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AspiraPathlabDi_mojoScore_4130189.png",
        "date": "2026-07-31 10:10:03",
        "description": "Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-diagnostics-ltd-is-rated-sell-4109015",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AspiraPathlabDi_mojoScore_4109015.png",
        "date": "2026-07-20 10:10:41",
        "description": "Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date perspective on its performance and outlook."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-amp-diagnostics-ltd-is-rated-sell-4093537",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AspiraPathlabDi_mojoScore_4093537.png",
        "date": "2026-07-08 10:10:04",
        "description": "Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 July 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-amp-diagnostics-ltd-is-rated-sell-4074939",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AspiraPathlabDi_mojoScore_4074939.png",
        "date": "2026-06-27 10:10:34",
        "description": "Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 June 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Aspira Pathlab & Diagnostics Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/aspira-pathlab-amp-diagnostics-ltd-is-rated-sell-4055834",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AspiraPathlabDi_mojoScore_4055834.png",
        "date": "2026-06-16 10:11:10",
        "description": "Aspira Pathlab & Diagnostics Ltd is rated Sell by MarketsMOJO. This rating was last updated on 18 May 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 16 June 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trend, and technical outlook."
      }
    ],
    "total": 6177,
    "sid": "1002885",
    "stock_news_url": "https://www.marketsmojo.com/news/aspira-pathlab-diagnostics-1002885"
  },
  "announcements": [
    {
      "caption": "Intimation Of Book Closure Date Notice Of The 53Rd Annual General Meeting And E-Voting Date",
      "datetime": "31-Aug-2026",
      "details": "With reference to subject matter please find the attached Documents",
      "source": "BSE"
    },
    {
      "caption": "Reg. 34 (1) Annual Report.",
      "datetime": "31-Aug-2026",
      "details": "Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 please find enclosed copy of the Notice of the 31st AGM and the Annual Report for the financial year 2025-26 including the Audited Financial Statements for the year ended March 31 2026 (Annual Report) being sent by email to those members whose email addresses are registered with the Company/Depository Participant(s)",
      "source": "BSE"
    },
    {
      "caption": "Notice Convening 53Rd Annual General Meeting To Be Held On Friday September 25 2026 At 02.00 P.M Through Video Conferencing Mode.",
      "datetime": "31-Aug-2026",
      "details": "Intimation of Notice of 53rd Annual General Meeting for the Financial Year 2025-26",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Aspira Pathlab & Diagnostics Ltd is Rated Sell

2026-08-23 10:10:27

Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Aspira Pathlab & Diagnostics Ltd is Rated Sell

2026-08-11 10:10:57

Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

When is the next results date for Aspira Pathlab & Diagnostics Ltd?

2026-08-07 23:20:59

The next results date for Aspira Pathlab & Diagnostics Ltd is scheduled for 12 August 2026....

Read full news article

Aspira Pathlab & Diagnostics Ltd is Rated Sell

2026-07-31 10:10:03

Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Aspira Pathlab & Diagnostics Ltd is Rated Sell

2026-07-20 10:10:41

Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 July 2026, providing investors with an up-to-date perspective on its performance and outlook.

Read full news article

Aspira Pathlab & Diagnostics Ltd is Rated Sell

2026-07-08 10:10:04

Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 08 July 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Read full news article

Aspira Pathlab & Diagnostics Ltd is Rated Sell

2026-06-27 10:10:34

Aspira Pathlab & Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 18 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Aspira Pathlab & Diagnostics Ltd is Rated Sell

2026-06-16 10:11:10

Aspira Pathlab & Diagnostics Ltd is rated Sell by MarketsMOJO. This rating was last updated on 18 May 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 16 June 2026, providing investors with the most up-to-date insight into the stock’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

View All News